President-elect Donald Trump’s pick to lead NIH, Jay Bhattacharya, has made his career attacking the leadership and rank-and-file staffers at the institutes, argues Washington Editor Steve Usdin on the latest BioCentury This Week podcast. Usdin and colleagues discuss how Bhattacharya, should he be nominated and approved by the Senate, could lead NIH and how that could affect the biopharma industry.The BioCentury team then discusses its analysis of abstracts released ahead of the American Soci...